We cannot keep relying on our company’s reputation
to stand out – not in the Brave New World of Data! We need to be smart, strategic and
tech-savvy in order to reach new heights in precision, productivity and patient centricity

Data has become the new currency of productivity and ROI, and the pharmaceutical industry must face the challenges it brings head on, or risk losing the value story both in R&D and patient relationships. We need to move past the challenge of integrating unstructured data sets and collaborate on multiple levels with other departments and organisations to create a real world evidence framework for our product development through effective data utilisation.

This September, industry leaders from key pharma companies like Janssen, Merck, BERG Health, AstraZeneca, Celgene & GSK will be sharing their insights into the role of data analytics, discussing tangible method for data optimisation, and translating this into real world strategies for your company.

Are you an industry innovator trying to advance your company’s data utilisation? Are you intent on maximising your analytical capabilities and value, but unsure of your next steps? We all know that Data Analytics, or ‘Big Data’ is not new to the industry, but this year’s Data Analytics for Pharma Development Forum will ensure that you are at the forefront of innovative industry discussion and process excellence strategies!

Download the 2018 Draft Agenda